Primary central nervous system lymphomas express immunohistochemical factors of autophagy
Abstract Primary central nervous system lymphoma (PCNSL) is an aggressive and rare disease. Autophagy is a catabolic mechanism boosting various tumors, including lymphomas; its inhibition is thus a promising therapeutic target. Its presence has never been studied in PCNSLs. We conducted a retrospect...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/837f0784766340ea88d282e1ac2346c4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:837f0784766340ea88d282e1ac2346c4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:837f0784766340ea88d282e1ac2346c42021-11-21T12:24:38ZPrimary central nervous system lymphomas express immunohistochemical factors of autophagy10.1038/s41598-021-01693-62045-2322https://doaj.org/article/837f0784766340ea88d282e1ac2346c42021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-01693-6https://doaj.org/toc/2045-2322Abstract Primary central nervous system lymphoma (PCNSL) is an aggressive and rare disease. Autophagy is a catabolic mechanism boosting various tumors, including lymphomas; its inhibition is thus a promising therapeutic target. Its presence has never been studied in PCNSLs. We conducted a retrospective immunohistochemical study of 25 PCNSLs for LC3B, p62, and M6PR, comparing it with clinicopathological characteristics. Fourteen (56%) and eleven (44%) PCNSLs were of low and high LC3B expression, respectively. p62 expression was present in most tumors (n = 21, 84%). M6PR was present in all tumors, with 14 (56%) and 11 (44%) cases being of low and high M6PR expression, respectively. LC3B expression was correlated with the performance status (PS) (p = 0.04). No association was found with other clinical parameters, such as deep structure invasion, multiple lesions, complete response, and recurrence after response. p62 showed a strong positive association with MUM1 expression (p = 0.0005). M6PR expression showed a positive correlation (p = 0.04) with PD-L1 expression. No association was found with p53, Ki67, CD8, BCL2, BCL6, or double MYC/BLC2 co-expressors. No association of LC3B, p62, and M6PR expression with survival was found. Our findings provide evidence for the possible presence of autophagic markers in PCNSLs and, thus, for possible treatment targets.Georgia KarpathiouSilvia-Maria BabiucFlorian CamyElise FerrandAlexandra Papoudou-BaiJean Marc DumollardJerome CornillonMichel Peoc’hNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Georgia Karpathiou Silvia-Maria Babiuc Florian Camy Elise Ferrand Alexandra Papoudou-Bai Jean Marc Dumollard Jerome Cornillon Michel Peoc’h Primary central nervous system lymphomas express immunohistochemical factors of autophagy |
description |
Abstract Primary central nervous system lymphoma (PCNSL) is an aggressive and rare disease. Autophagy is a catabolic mechanism boosting various tumors, including lymphomas; its inhibition is thus a promising therapeutic target. Its presence has never been studied in PCNSLs. We conducted a retrospective immunohistochemical study of 25 PCNSLs for LC3B, p62, and M6PR, comparing it with clinicopathological characteristics. Fourteen (56%) and eleven (44%) PCNSLs were of low and high LC3B expression, respectively. p62 expression was present in most tumors (n = 21, 84%). M6PR was present in all tumors, with 14 (56%) and 11 (44%) cases being of low and high M6PR expression, respectively. LC3B expression was correlated with the performance status (PS) (p = 0.04). No association was found with other clinical parameters, such as deep structure invasion, multiple lesions, complete response, and recurrence after response. p62 showed a strong positive association with MUM1 expression (p = 0.0005). M6PR expression showed a positive correlation (p = 0.04) with PD-L1 expression. No association was found with p53, Ki67, CD8, BCL2, BCL6, or double MYC/BLC2 co-expressors. No association of LC3B, p62, and M6PR expression with survival was found. Our findings provide evidence for the possible presence of autophagic markers in PCNSLs and, thus, for possible treatment targets. |
format |
article |
author |
Georgia Karpathiou Silvia-Maria Babiuc Florian Camy Elise Ferrand Alexandra Papoudou-Bai Jean Marc Dumollard Jerome Cornillon Michel Peoc’h |
author_facet |
Georgia Karpathiou Silvia-Maria Babiuc Florian Camy Elise Ferrand Alexandra Papoudou-Bai Jean Marc Dumollard Jerome Cornillon Michel Peoc’h |
author_sort |
Georgia Karpathiou |
title |
Primary central nervous system lymphomas express immunohistochemical factors of autophagy |
title_short |
Primary central nervous system lymphomas express immunohistochemical factors of autophagy |
title_full |
Primary central nervous system lymphomas express immunohistochemical factors of autophagy |
title_fullStr |
Primary central nervous system lymphomas express immunohistochemical factors of autophagy |
title_full_unstemmed |
Primary central nervous system lymphomas express immunohistochemical factors of autophagy |
title_sort |
primary central nervous system lymphomas express immunohistochemical factors of autophagy |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/837f0784766340ea88d282e1ac2346c4 |
work_keys_str_mv |
AT georgiakarpathiou primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy AT silviamariababiuc primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy AT floriancamy primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy AT eliseferrand primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy AT alexandrapapoudoubai primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy AT jeanmarcdumollard primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy AT jeromecornillon primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy AT michelpeoch primarycentralnervoussystemlymphomasexpressimmunohistochemicalfactorsofautophagy |
_version_ |
1718419017415262208 |